Who Owns Madrigal Pharmaceuticals Stock?
NASDAQ: MDGLHealthcareBiotechnologyUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 104.65%
- Institutions (% of float)
- 111.13%
- Held by insiders
- 5.83%
- Institutional holders
- 562
- Institutions 94.2%
- Insiders 5.8%
- Public and other 0.0%
Who owns Madrigal Pharmaceuticals stock?
Institutional investors own about 104.7% of Madrigal Pharmaceuticals's shares, spread across 562 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 5.83% of MDGL.
The largest institutional holders are Baker Bros. Advisors, LP (9.28%), RTW Investments LP (8.63%) and Jupiter Topco LLC (8.38%). Together, the top 10 institutions control 58.1% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their MDGL positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of MDGL
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Baker Bros. Advisors, LP | 2.14M | 9.28% | +0.1% |
| RTW Investments LP | 1.99M | 8.63% | 0.0% |
| Jupiter Topco LLC | 1.94M | 8.38% | +100.0% |
| Avoro Capital Advisors LLC | 1.83M | 7.94% | +0.8% |
| PAULSON & CO. INC. | 1.34M | 5.80% | -3.8% |
| Blackrock Inc. | 1.20M | 5.20% | -23.0% |
| Vanguard Capital Management LLC | 835.67K | 3.62% | +1.0% |
| Wellington Management Group, LLP | 825.71K | 3.57% | +18.8% |
| Vanguard Portfolio Management LLC | 781.73K | 3.38% | -7.1% |
| State Street Corporation | 527.06K | 2.28% | -13.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of MDGL
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 585.00K | 2.53% |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 563.12K | 2.44% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 423.14K | 1.83% |
| JANUS INVESTMENT FUND-Janus Henderson Forty Fund | 338.60K | 1.47% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 243.68K | 1.05% |
| JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund | 233.27K | 1.01% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 222.41K | 0.96% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 216.88K | 0.94% |
| Vanguard Explorer Fund | 190.14K | 0.82% |
| First TRT Exch-Trd Fd.-First TRT NYSE Arca Biotechnology Index Fd. | 168.69K | 0.73% |
Frequently asked questions
Who is the largest shareholder of Madrigal Pharmaceuticals?
Baker Bros. Advisors, LP is the largest institutional shareholder of MDGL, owning 9.28% of shares outstanding (2.14M shares) as of its latest 13F filing.
What percentage of Madrigal Pharmaceuticals is owned by institutions?
Institutions own about 104.7% of MDGL shares and 111.1% of the public float.
How much of Madrigal Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 5.83% of MDGL shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.